Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Zydus Group has introduced a "reusable multi-dose pen" device, aimed at improving convenience and reducing overall therapy costs for patients
More serious considerations include risk of pancreatitis, gallbladder problems, kidney injury (often related to dehydration from gastrointestinal symptoms), and rare cases of medullary thyroid cancer (these medications carry a black box warning for patients with personal or family history of MTC or MEN2 syndrome)
Only the delivery mechanism changes
The regulatory landscape is littered with recalled drugs that passed safety checks in initial short-term, small-scale approval trials, but foundered years after when danger signals emerged only after millions unwittingly took the medications
